KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Oct 16, 2025 - 3:59PM >>  ABB India 5205  [ 0.63% ]  ACC 1862  [ 0.23% ]  Ambuja Cements 569.7  [ 0.51% ]  Asian Paints Ltd. 2410  [ 1.48% ]  Axis Bank Ltd. 1196.95  [ 2.39% ]  Bajaj Auto 9152.9  [ 1.67% ]  Bank of Baroda 266.2  [ -0.82% ]  Bharti Airtel 1967.45  [ -0.09% ]  Bharat Heavy Ele 235.95  [ 0.06% ]  Bharat Petroleum 335.9  [ -0.56% ]  Britannia Ind. 6011.55  [ 2.64% ]  Cipla 1572.2  [ 0.92% ]  Coal India 387.6  [ 0.92% ]  Colgate Palm. 2285.2  [ 2.57% ]  Dabur India 500.45  [ 1.42% ]  DLF Ltd. 770  [ 1.85% ]  Dr. Reddy's Labs 1241.05  [ 0.69% ]  GAIL (India) 179.2  [ 1.04% ]  Grasim Inds. 2859  [ 1.54% ]  HCL Technologies 1516.05  [ 1.33% ]  HDFC Bank 994.2  [ 1.54% ]  Hero MotoCorp 5577.1  [ 0.69% ]  Hindustan Unilever L 2565  [ 1.77% ]  Hindalco Indus. 779.3  [ 1.97% ]  ICICI Bank 1416.6  [ 1.30% ]  Indian Hotels Co 736.3  [ 1.13% ]  IndusInd Bank 738.3  [ -0.28% ]  Infosys L 1473.35  [ -0.04% ]  ITC Ltd. 405.35  [ 1.32% ]  Jindal Steel 1021.85  [ 2.07% ]  Kotak Mahindra Bank 2207.9  [ 2.76% ]  L&T 3865.2  [ 1.06% ]  Lupin Ltd. 1951  [ 0.53% ]  Mahi. & Mahi 3565.4  [ 1.95% ]  Maruti Suzuki India 16303.75  [ 0.52% ]  MTNL 42.16  [ -0.02% ]  Nestle India 1277.55  [ 4.58% ]  NIIT Ltd. 106.2  [ 0.47% ]  NMDC Ltd. 75.97  [ -0.94% ]  NTPC 341.75  [ 0.69% ]  ONGC 248.1  [ 0.10% ]  Punj. NationlBak 116.05  [ -0.30% ]  Power Grid Corpo 291.95  [ 0.17% ]  Reliance Inds. 1398.5  [ 1.73% ]  SBI 887.45  [ 0.14% ]  Vedanta 478.7  [ -0.85% ]  Shipping Corpn. 229.15  [ -1.80% ]  Sun Pharma. 1661.7  [ 0.46% ]  Tata Chemicals 922.05  [ 2.11% ]  Tata Consumer Produc 1150.1  [ 3.25% ]  Tata Motors 397.2  [ 1.65% ]  Tata Steel 174.25  [ 0.64% ]  Tata Power Co. 399  [ 0.67% ]  Tata Consultancy 2972.85  [ 0.13% ]  Tech Mahindra 1464.9  [ 0.40% ]  UltraTech Cement 12362.05  [ 0.45% ]  United Spirits 1359.25  [ 1.98% ]  Wipro 253.85  [ 1.46% ]  Zee Entertainment En 109.9  [ -0.05% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

AAREY DRUGS & PHARMACEUTICALS LTD.

16 October 2025 | 03:15

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE198H01019 BSE Code / NSE Code 524412 / AAREYDRUGS Book Value (Rs.) 46.93 Face Value 10.00
Bookclosure 30/09/2024 52Week High 89 EPS 1.42 P/E 62.42
Market Cap. 251.16 Cr. 52Week Low 31 P/BV / Div Yield (%) 1.89 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd.

The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate.

2008

-Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008.

2012

-Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1

-Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5

2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.